{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:52:15Z","timestamp":1773460335391,"version":"3.50.1"},"reference-count":79,"publisher":"Baishideng Publishing Group Inc.","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3748\/wjg.v20.i33.11641","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:27:19Z","timestamp":1410222439000},"page":"11641","source":"Crossref","is-referenced-by-count":21,"title":["Management of antiviral drug resistance in chronic hepatitis B"],"prefix":"10.3748","volume":"20","author":[{"given":"Ki Bae","family":"Bang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.56.070187.003251"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51-68.","DOI":"10.1128\/MMBR.64.1.51-68.2000"},{"key":"ref3","unstructured":"Okamoto H, Imai M, Kametani M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med 1987;57:231-236."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(89)90455-8"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.9.4398"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1586\/14789072.2.6.853"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(12)60012-9"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Domingo E. Quasispecies and the development of new antiviral strategies. Prog Drug Res 2003;60:133-158.","DOI":"10.1007\/978-3-0348-8012-1_4"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.21.11833-11841.2003"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11100"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01499-06"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1998;27:628-633.","DOI":"10.1002\/hep.510270243"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/368083"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02410.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Chae HB, Hann HW. Baseline HBV DNA level is the most important factor associated with virologic breakthrough in chronic hepatitis B treated with lamivudine. World J Gastroenterol 2007;13:4085-4090.","DOI":"10.3748\/wjg.v13.i30.4085"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.02.021"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00915.x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00712.x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20701"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051214"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02477-05"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.018"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00700-5"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20016"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840400407"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-307"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27563"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00853.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066422"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.09.020"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.10.3729-3734.2002"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3350\/kjhep.2012.18.1.75"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.026"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.05.007"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-915645"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02671.x"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Qi X, Xiong S, Yang H, Miller M, Delaney WE. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther 2007;12:355-362.","DOI":"10.1177\/135965350701200309"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.051"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21189"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.077099"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Fung J, Lai CL, Yuen JC, Wong DK, Tanaka Y, Mizokami M, Yuen MF. Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population. Antivir Ther 2007;12:41-46.","DOI":"10.1177\/135965350701200109"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.08.079"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20939"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06381"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22841"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20464"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21253"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23246"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Sheldon J, Camino N, Rodés B, Bartholomeusz A, Kuiper M, Tacke F, Nú\u00f1ez M, Mauss S, Lutz T, Klausen G. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther 2005;10:727-734.","DOI":"10.1177\/135965350501000612"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9045-6"},{"key":"ref52","unstructured":"Patel N, Ama rapurkar D. Tenofovir rescue therapy for patients with viral resistance to lamivudine and\/or adefovir treatment. Hepatol Int 2010;4:161."},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34740"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00939-9"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Locarnini SQX, Arterburn S, Snow A, Brosgart CL, Currie G, Wulfsohn M, Miller MD, Xiong S. Incidence and predictors of emergence of HBV mutations associated with ADV resistance during 4 Years of ADV therapy for patients with chronic hepatitis B. J Hepatol 2005;42:17.","DOI":"10.1016\/S0168-8278(05)81448-5"},{"key":"ref56","unstructured":"Borroto-Esoda K, Miller MD, Arterburn S. Metaanalysis across adefovir clinical trials demonstrates the absence of novel adefovir-associated mutations and confirms the role of the rtA181V and rtA236T mutations in HBV polymerase with virologic failure. Hepatology 2006;44:552A."},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20723"},{"key":"ref58","unstructured":"Villet S, Pichoud C, Trepo C, Zoulim F. Selection of the A181T\/V substitution in HBV chronically infected patients who developed a resistance to lamivudine and\/or adefovir. Hepatology 2006;44:555A."},{"key":"ref59","unstructured":"Qi X, Xiong S, Yang H, Miller MD, Delaney W. In vitro susceptibility of HBV polymerase encoding mutations acquired during adefovir dipivoxil therapy to other Anti-HBV agents. Hepatology 2006;44:252A."},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1136\/gut"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.09.020"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.01.027"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.037"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.012"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23145"},{"key":"ref66","unstructured":"Lim YS, Lee TH, Heo NY, Shim JH, Suh DJ. Entecavir plus adefovir combination for chronic hepatitis B patients after failure of nucleos(t)ide analogue. Korean J Gastroenterol 2010;56:A293."},{"key":"ref67","unstructured":"Petersen J, Lutgehetmann M, Zoulim F, Sterneck M, Janssen HL, Berg T, Buggisch P, Lampertico P, Ratziu V, Buti M. Entecavir and tenofovir combination therpy in chronic hepatitis B: rescue therapy in patients with advanced fibrosis and multiple previous treatment failures. Results from an international multicenter cohort study. Hepatoloy 2009;50:496A."},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.11.016"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20981"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2294"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22790"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9048-3"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i47.6996"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23190"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9080-3"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1510"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835ee516"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1159\/000353851"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-162"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i33\/11641.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T16:24:38Z","timestamp":1650126278000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i33\/11641.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":79,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v20.i33.11641","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}